Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Phase III Trial Under Way For Icagen's Sickle Cell Product

Feb. 23, 2005

By Aaron Lorenzo

Phase III Trial Under Way For Icagen's Sickle Cell Product

Feb. 23, 2005

By Aaron Lorenzo

FDA Committee Members Vote To Let Vioxx Return To Market

Feb. 22, 2005

By Aaron Lorenzo

FDA Committee Members Vote To Let Vioxx Return To Market

Feb. 22, 2005

By Aaron Lorenzo

FDA Doctor Questions Need For Any Drugs From the COX-2 Class

Feb. 18, 2005

By Aaron Lorenzo

FDA Doctor Questions Need For Any Drugs From the COX-2 Class

Feb. 18, 2005

By Aaron Lorenzo

Pfizer Defends Celebrex As FDA Meets On Safety Of COX-2 Class

Feb. 17, 2005

By Aaron Lorenzo

Pfizer Defends Celebrex As FDA Meets On Safety Of COX-2 Class

Feb. 17, 2005

By Aaron Lorenzo

Crawford Receives Bush's Nomination As FDA Head

Feb. 16, 2005

By Aaron Lorenzo

Crawford Receives Bush's Nomination As FDA Head

Feb. 16, 2005

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026